Annals of Emergency Medicine
Volume 42, Issue 3 , Pages 365-369 , September 2003

Coronary no-flow and ventricular tachycardia associated with habitual marijuana use

  • Shereif H Rezkalla, MD

      Affiliations

    • Department of Cardiology, Marshfield Clinic, Marshfield, WI, USA
    • Corresponding Author InformationAddress for reprints: Shereif H. Rezkalla, MD, Director of Cardiovascular Research, Department of Cardiology, Marshfield Clinic, 1000 North Oak Avenue, Marshfield, WI 54449; 715-387-5845, fax 715-389-3808
  • ,
  • Param Sharma, MD

      Affiliations

    • Department of Cardiology, Marshfield Clinic, Marshfield, WI, USA
  • ,
  • Robert A Kloner, MD, PhD

      Affiliations

    • The Heart Institute, Good Samaritan Hospital, Los Angeles, CA, USA

Received 20 December 2002 ,Revised 9 April 2003 ,Accepted 17 April 2003.

References 

    References
  1. AnonymousCannibis, 1977 Ann Intern Med. 1978;89:539-549.
  2. Charles R, Holt S, Kirkham N. Myocardial infarction and marijuana. Clin Toxicol. 1979;14:433–438
  3. Collins JS, Higginson JD, Boyle DM, et al.  Myocardial infarction during marijuana smoking in a young female. Eur Heart J. 1985;6:637–638
  4. Wang T, Hadidi F, Triana F, et al.  Myocardial infarction associated with the use of cocaine. Am J Med Sci. 1988;295:569–571
  5. Mittleman MA, Lewis RA, Maclure M, et al.  Triggering myocardial infarction by marijuana. Circulation. 2001;103:2805–2809
  6. Bachs L, Morland H. Acute cardiovascular fatalities following cannabis use. Forensic Sci Int. 2001;124:200–203
  7. Gregg JM, Campbell RL, Levin KJ, et al.  Cardiovascular effects of cannabinol during oral surgery. Anesth Analg. 1976;55:203–213
  8. Kiplinger GF, Manno JE. Dose-response relationships to cannabis in human subjects. Pharmacol Rev. 1971;23:339–347
  9. Renault PF, Schuster CR, Heinrich R, et al.  Marihuana: standardized smoke administration and dose effect curves on heart rate in humans. Science. 1971;174:589–591
  10. Huestis MA, Gorelick DA, Heishman SJ, et al.  Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry. 2001;58:322–328
  11. Beaconsfield P, Ginsburg J, Rainsbury R. Marihuana smokingCardiovascular effects in man and possible mechanisms. N Engl J Med. 1972;287:209–212
  12. Aronow WS, Cassidy J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med. 1974;291:65–67
  13. Zipes DP, Foster PR, Troup PJ, et al.  Atrial induction of ventricular tachycardia: reentry versus triggered automaticity. Am J Cardiol. 1979;44:1–8
  14. Belhassen B, Rotmensch HH, Laniado S. Response of recurrent sustained ventricular tachycardia to verapamil. Br Heart J. 1981;46:679–682
  15. MacInnes DC, Miller KM. Fatal coronary artery thrombosis associated with cannabis smoking. J R Coll Gen Pract. 1984;34:575–576
  16. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation. 2002;105:656–662

 The authors report this study did not receive any outside funding or support.

PII: S0196-0644(03)00426-8

doi: 10.1016/S0196-0644(03)00426-8

Annals of Emergency Medicine
Volume 42, Issue 3 , Pages 365-369 , September 2003